Trials / Withdrawn
WithdrawnNCT04383756
Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We will study 40 matched patients. 20 patients will receive leukoreduced whole blood from the solid organ donor. These 20 patients will be compared to 20 historical matched controls with regards to allogenic blood product usage and other physiologic markers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Donor Blood | Up to 4 units (each unit contains 350mL) of leukoreduced donor whole blood |
| BIOLOGICAL | Banked Blood | Up to 350mL of Allogenic banked component blood transfusion in a 1:1:1 manner (packed red blood cells : plasma : platelets) |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
- First posted
- 2020-05-12
- Last updated
- 2022-03-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04383756. Inclusion in this directory is not an endorsement.